Veterinary Oncology Market Size, Share & Trends Analysis Report By Therapy (Radiology, Chemotherapy), By Animal type, By Cancer type (Lymphoma, Mast cells, Mammary and Squamous cell), By Region, And Segment Forecasts, 2022 - 2030
This report can be delivered to the clients within 72 Business Hours
Veterinary Oncology Market Growth & Trends
The global veterinary oncology market size is expected to reach USD 578.0 million by 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.
Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.
Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.
Veterinary Oncology Market Report Highlights
Veterinary Oncology Market Growth & Trends
The global veterinary oncology market size is expected to reach USD 578.0 million by 2030, according to a new report by Grand View Research, Inc. Increasing prevalence of cancer in pets and demand for veterinary diagnostics are projected to drive the market over the forecast period.
Adoption of canine cancer registry globally to estimate cancer incidences is another driving factor for the market growth. According to frontiers in Veterinary Science in February 2019, the Swiss Canine Cancer Registry (SCCR) was used as a data source and was compiled for future comparative studies of canine and human cancers. This database is further helpful in mitigating the incidence of malignant tumors in the human population, thereby driving the market growth.
Researchers carrying out studies focused on veterinary oncology are further boosting the veterinary oncology market growth. For instance, University of Illinois in August 2017, carried out study that involves more precise detection of metastasis (spread of cancer through the body) for head and neck tumors in dogs. Moreover, the market players are also focusing on new product innovation and strategic collaborations. For instance, in 2018 AdvaVet, a subsidiary of Oasmia Pharmaceutical AB, developed XR17 technology, which is nanoparticle formulation based that makes a single Active Pharmaceutical Ingredient (API) or multiple APIs water soluble. It is a combination therapy and is also a standard treatment for a number of cancer diseases in pet animals.
Veterinary Oncology Market Report Highlights
- Increasing prevalence of cancer in companion animals, several clinical trial studies to evaluate the safety and effectiveness of cancer therapeutics for pets and technological advancements in veterinary oncology treatment are anticipated to create growth opportunities in the market.
- Chemotherapy accounted for the largest revenue share over the coming years, owing to its increasing adoption for pet cancer treatment either alone or in combination with other therapies.
- Canine segment held the largest revenue in 2021, increasing population of dogs and high prevalence of cancer in dogs as compared to cats.
- Lymphoma dominated the market among other cancer types in 2021, due to the disease's high mortality rate in companion animals. According to the Veterinary and Comparative Oncology in 2018, Gastrointestinal (GI) Lymphoma is the most common neoplasm that contracts dog population.
- North America held the dominant share of as of 2021, due to the favorable government policies, new product launch by the companies, and huge investment for veterinary oncology treatment.
- Asia Pacific is anticipated to witness lucrative growth due to increasing focus on animal health and expenditure, increasing number of pet population being exposed to cancer, government focus on animal safety, and several initiatives to curb cancer cases in pet animals.
- Some of the key companies are Boehringer Ingelheim, PetCure Oncology, Elanco, Accuray Incorporated, Varian Medical Systems, Zoetis, Karyopharm Therapeutics, Inc. One Health and Regeneus Ltd.
CHAPTER 1 RESEARCH METHODOLOGY & SCOPE
1.1 Market Segmentation & Scope
1.1.1 Segment Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Target Population & Patient Stratification (Top-down estimation): mODEL
1.6.2 Assumptions/Key Considerations
1.6.3 Commodity Flow Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Abbreviations
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Veterinary Oncology Market Summary, 2021
2.2 Segment Outlook
2.3 Competitive Outlook
CHAPTER 3 VETERINARY ONCOLOGY MARKET VARIABLES TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping by Technology, 2021
3.3 User Perspective Analysis
3.3.1 Market Influencer Analysis
3.3.2 List of Key End Users
3.4 Regulatory Framework
3.4.1 Regulatory Landscape
3.4.2 Standards & compliances
3.5 Technology Timeline Analysis
3.6 Veterinary Oncology Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Increasing prevalence and incidence of cancer in pets
3.6.1.2 Growing Research and investments in pet cancer therapy
3.6.1.3 Rising focus on animal safety
3.6.1.4 Increasing adoption of pet insurance
3.6.1.5 Technological advancements in pet cancer treatment
3.6.2 Market restraint analysis
3.6.2.1 High cost of pet cancer treatments
3.6.2.2 Lack of awareness among pet owners about pet diseases
3.6.2.3 Adverse effects of drugs used for pet cancer treatment
3.7 Industry Analysis - Porter’s
3.7.1 Bargaining Power of suppliers: Moderate
3.7.2 Bargaining Power of buyers: Low to Moderate
3.7.3 Threat of Substitutes: Moderate
3.7.4 Threat of New entrants: High
3.7.5 Competitive Rivalry: High
3.8 U.S. Veterinary Oncology - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.8.1 Political and Legal landscape
3.8.2 Economic Landscape
3.8.3 Social Landscape
3.8.4 Technology Landscape
3.9 Covid Impact Analysis
3.9.1 COVID-19 Prevalence Analysis
3.9.2 Impact of COVID-19 on the Market
3.9.2.1 Impact on market Players
3.9.3 Regulatory/Policy Changes
3.9.4 Strategies Adopted by Market Players
3.9.5 Future Impact Analysis
CHAPTER 4 VETERINARY ONCOLOGY MARKET: COMPETITIVE ANALYSIS
4.1 Market Participation Categorization
4.2 Competitive Analysis
4.2.1 Company market position analysis
4.2.2 Market leaders & Innovators
4.2.2.1 Market leaders
4.2.2.2 Market Innovators
4.3 Major Deals & Strategic Alliances Analysis
4.4 Vendor Landscape
4.4.1 List of Veterinary Oncology Service Providers
CHAPTER 5 VETERINARY ONCOLOGY MARKET: THERAPY ESTIMATES & TREND ANALYSIS
5.1 Therapy Market Share Analysis, 2021 & 2030
5.2 Therapy Dashboard
5.3 Surgery
5.3.1 Surgery market estimates and forecasts, 2016 - 2030 (USD Million)
5.4 Radiotherapy
5.4.1 Radiotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
5.5 Chemotherapy
5.5.1 Chemotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
5.6 Immunotherapy
5.6.1 Immunotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
5.7 Others
5.7.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 6 VETERINARY ONCOLOGY MARKET: ANIMAL TYPE ESTIMATES & TREND ANALYSIS
6.1 Animal Type Market Share Analysis, 2021 & 2030
6.2 Animal Type Dashboard
6.3 Canine
6.3.1 Canine market estimates and forecasts, 2016 - 2030 (usd million)
6.4 Feline
6.4.1 Feline market estimates and forecasts, 2016 - 2030 (usd million)
CHAPTER 7 VETERINARY ONCOLOGY MARKET: CANCER TYPE ESTIMATES & TREND ANALYSIS
7.1 Cancer Type Market Share Analysis, 2020 & 2028
7.2 Cancer Type Dashboard
7.3 Lymphoma
7.3.1 Lymphoma market estimates and forecasts, 2016 - 2030 (USD Million)
7.4 Mast Cell Cancer
7.4.1 Mast Cell Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
7.5 Mammary and Squamous Cell Cancer
7.5.1 Mammary and Squamous Cell Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
7.6 Others
7.6.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 8 VETERINARY ONCOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT, ANIMAL TYPE, AND END-USE
8.1 Veterinary Oncology Market Shares By Region, 2021 & 2030
8.2 North America
8.2.1 North America Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4.2 China
8.4.2.1 China Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.6 Middle East & Africa
8.6.1 MEA Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 SOuth Africa Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 9 COMPANY PROFILES
9.1 Boehringer Ingelheim International GmbH
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Elanco
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Zoetis
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 PetCure Oncology
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 Accuray Incorporated
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 Varian Medical Systems, Inc.
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
9.7.1 Company overview
9.7.2 Product benchmarking
9.7.3 Strategic initiatives
9.8 Morphogenesis
9.8.1 Company overview
9.8.2 Product benchmarking
9.8.3 Strategic initiatives
9.9 Karyopharm
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Regeneus Ltd.
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic Initiatives
9.11 OHC (One Health Company)
9.11.1 Company overview
9.11.2 Product benchmarking
9.11.3 Strategic Initiatives
1.1 Market Segmentation & Scope
1.1.1 Segment Scope
1.1.2 Estimates and Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database
1.3.2 GVR’s Internal Database
1.3.3 Secondary sources
1.3.4 Primary Research:
1.3.5 Details of Primary Research
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Target Population & Patient Stratification (Top-down estimation): mODEL
1.6.2 Assumptions/Key Considerations
1.6.3 Commodity Flow Analysis (Model 2)
1.7 List of Secondary Sources
1.8 Abbreviations
1.9 Report Objectives
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market Outlook
2.1.1 Veterinary Oncology Market Summary, 2021
2.2 Segment Outlook
2.3 Competitive Outlook
CHAPTER 3 VETERINARY ONCOLOGY MARKET VARIABLES TRENDS & SCOPE
3.1 Market Lineage Outlook
3.1.1 Parent market outlook
3.1.2 Ancillary market outlook
3.2 Penetration & Growth Prospect Mapping by Technology, 2021
3.3 User Perspective Analysis
3.3.1 Market Influencer Analysis
3.3.2 List of Key End Users
3.4 Regulatory Framework
3.4.1 Regulatory Landscape
3.4.2 Standards & compliances
3.5 Technology Timeline Analysis
3.6 Veterinary Oncology Market Dynamics
3.6.1 Market driver analysis
3.6.1.1 Increasing prevalence and incidence of cancer in pets
3.6.1.2 Growing Research and investments in pet cancer therapy
3.6.1.3 Rising focus on animal safety
3.6.1.4 Increasing adoption of pet insurance
3.6.1.5 Technological advancements in pet cancer treatment
3.6.2 Market restraint analysis
3.6.2.1 High cost of pet cancer treatments
3.6.2.2 Lack of awareness among pet owners about pet diseases
3.6.2.3 Adverse effects of drugs used for pet cancer treatment
3.7 Industry Analysis - Porter’s
3.7.1 Bargaining Power of suppliers: Moderate
3.7.2 Bargaining Power of buyers: Low to Moderate
3.7.3 Threat of Substitutes: Moderate
3.7.4 Threat of New entrants: High
3.7.5 Competitive Rivalry: High
3.8 U.S. Veterinary Oncology - SWOT Analysis, by Factor (Political & Legal, Economic, Social and Technological)
3.8.1 Political and Legal landscape
3.8.2 Economic Landscape
3.8.3 Social Landscape
3.8.4 Technology Landscape
3.9 Covid Impact Analysis
3.9.1 COVID-19 Prevalence Analysis
3.9.2 Impact of COVID-19 on the Market
3.9.2.1 Impact on market Players
3.9.3 Regulatory/Policy Changes
3.9.4 Strategies Adopted by Market Players
3.9.5 Future Impact Analysis
CHAPTER 4 VETERINARY ONCOLOGY MARKET: COMPETITIVE ANALYSIS
4.1 Market Participation Categorization
4.2 Competitive Analysis
4.2.1 Company market position analysis
4.2.2 Market leaders & Innovators
4.2.2.1 Market leaders
4.2.2.2 Market Innovators
4.3 Major Deals & Strategic Alliances Analysis
4.4 Vendor Landscape
4.4.1 List of Veterinary Oncology Service Providers
CHAPTER 5 VETERINARY ONCOLOGY MARKET: THERAPY ESTIMATES & TREND ANALYSIS
5.1 Therapy Market Share Analysis, 2021 & 2030
5.2 Therapy Dashboard
5.3 Surgery
5.3.1 Surgery market estimates and forecasts, 2016 - 2030 (USD Million)
5.4 Radiotherapy
5.4.1 Radiotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
5.5 Chemotherapy
5.5.1 Chemotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
5.6 Immunotherapy
5.6.1 Immunotherapy market estimates and forecasts, 2016 - 2030 (USD Million)
5.7 Others
5.7.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 6 VETERINARY ONCOLOGY MARKET: ANIMAL TYPE ESTIMATES & TREND ANALYSIS
6.1 Animal Type Market Share Analysis, 2021 & 2030
6.2 Animal Type Dashboard
6.3 Canine
6.3.1 Canine market estimates and forecasts, 2016 - 2030 (usd million)
6.4 Feline
6.4.1 Feline market estimates and forecasts, 2016 - 2030 (usd million)
CHAPTER 7 VETERINARY ONCOLOGY MARKET: CANCER TYPE ESTIMATES & TREND ANALYSIS
7.1 Cancer Type Market Share Analysis, 2020 & 2028
7.2 Cancer Type Dashboard
7.3 Lymphoma
7.3.1 Lymphoma market estimates and forecasts, 2016 - 2030 (USD Million)
7.4 Mast Cell Cancer
7.4.1 Mast Cell Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
7.5 Mammary and Squamous Cell Cancer
7.5.1 Mammary and Squamous Cell Cancer market estimates and forecasts, 2016 - 2030 (USD Million)
7.6 Others
7.6.1 Others market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 8 VETERINARY ONCOLOGY MARKET: REGIONAL ESTIMATES & TREND ANALYSIS, BY PRODUCT, ANIMAL TYPE, AND END-USE
8.1 Veterinary Oncology Market Shares By Region, 2021 & 2030
8.2 North America
8.2.1 North America Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.2.2 U.S.
8.2.2.1 U.S. Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.2.3 Canada
8.2.3.1 Canada Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3 Europe
8.3.1 Europe Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.2 Germany
8.3.2.1 Germany Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.3 U.K.
8.3.3.1 U.K. Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.4 France
8.3.4.1 France Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.5 Italy
8.3.5.1 Italy Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.3.6 Spain
8.3.6.1 Spain Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4.2 China
8.4.2.1 China Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4.3 Japan
8.4.3.1 Japan Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.4.4 India
8.4.4.1 India Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.5 Latin America
8.5.1 Latin America Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.5.2 Brazil
8.5.2.1 Brazil Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.5.3 Mexico
8.5.3.1 Mexico Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.6 Middle East & Africa
8.6.1 MEA Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
8.6.2 South Africa
8.6.2.1 SOuth Africa Veterinary Oncology market estimates and forecasts, 2016 - 2030 (USD Million)
CHAPTER 9 COMPANY PROFILES
9.1 Boehringer Ingelheim International GmbH
9.1.1 Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.2 Elanco
9.2.1 Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.3 Zoetis
9.3.1 Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.4 PetCure Oncology
9.4.1 Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.5 Accuray Incorporated
9.5.1 Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.6 Varian Medical Systems, Inc.
9.6.1 Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.7 Nippon Zenyaku Kogyo Co. Ltd. (ZENOAQ)
9.7.1 Company overview
9.7.2 Product benchmarking
9.7.3 Strategic initiatives
9.8 Morphogenesis
9.8.1 Company overview
9.8.2 Product benchmarking
9.8.3 Strategic initiatives
9.9 Karyopharm
9.9.1 Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.10 Regeneus Ltd.
9.10.1 Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic Initiatives
9.11 OHC (One Health Company)
9.11.1 Company overview
9.11.2 Product benchmarking
9.11.3 Strategic Initiatives
LIST OF TABLES
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 List of veterinary oncology service providers
TABLE 4 North America veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 5 North America veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 6 North America veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 7 U.S. veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 8 U.S. veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 9 U.S. veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 10 Canada veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 11 Canada veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 12 Canada veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 13 Europe veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 14 Europe veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 15 Europe veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 16 U.K. veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 17 U.K. veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 18 U.K. veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 19 Germany veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 20 Germany veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 21 Germany veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 22 France veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 23 France veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 24 France veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 25 Italy veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 26 Italy veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 27 Italy veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 28 Spain veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 29 Spain veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 30 Spain veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 31 Asia Pacific veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 32 Asia Pacific veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 33 Asia Pacific veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 34 China veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 35 China veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 36 China veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 37 Japan veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 38 Japan veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 39 Japan veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 40 India veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 41 India veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 42 India veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 43 Latin America veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 44 Latin America veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 45 Latin America veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 46 Brazil veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 47 Brazil veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 48 Brazil veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 49 Mexico veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 50 Mexico veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 51 Mexico veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 52 MEA veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 53 MEA veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 54 MEA veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 55 South Africa veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 56 South Africa oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 57 South Africa oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 1 List of secondary sources
TABLE 2 List of abbreviation
TABLE 3 List of veterinary oncology service providers
TABLE 4 North America veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 5 North America veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 6 North America veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 7 U.S. veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 8 U.S. veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 9 U.S. veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 10 Canada veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 11 Canada veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 12 Canada veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 13 Europe veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 14 Europe veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 15 Europe veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 16 U.K. veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 17 U.K. veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 18 U.K. veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 19 Germany veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 20 Germany veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 21 Germany veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 22 France veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 23 France veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 24 France veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 25 Italy veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 26 Italy veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 27 Italy veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 28 Spain veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 29 Spain veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 30 Spain veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 31 Asia Pacific veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 32 Asia Pacific veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 33 Asia Pacific veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 34 China veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 35 China veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 36 China veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 37 Japan veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 38 Japan veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 39 Japan veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 40 India veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 41 India veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 42 India veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 43 Latin America veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 44 Latin America veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 45 Latin America veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 46 Brazil veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 47 Brazil veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 48 Brazil veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 49 Mexico veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 50 Mexico veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 51 Mexico veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 52 MEA veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 53 MEA veterinary oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 54 MEA veterinary oncology market, by cancer type, 2017 - 2030 (USD Million)
TABLE 55 South Africa veterinary oncology market, by Therapy, 2017 - 2030 (USD Million)
TABLE 56 South Africa oncology market, by animal type, 2017 - 2030 (USD Million)
TABLE 57 South Africa oncology market, by cancer type, 2017 - 2030 (USD Million)
LIST OF FIGURES
FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Target population & treatment rate for the U.S.
FIG. 10 Treatment cost analysis
FIG. 11 Commodity flow analysis
FIG. 12 Veterinary oncology market snapshot 2021 (USD Million)
FIG. 13 Parent market outlook
FIG. 14 Ancillary market outlook
FIG. 15 Penetration &growth prospect mapping by Technology, 2021
FIG. 16 Consumer behavior analysis
FIG. 17 Market influencing analysis
FIG. 18 Technology timeline analysis
FIG. 19 Veterinary Oncology market dynamics
FIG. 20 Veterinary Oncology market driver impact
FIG. 21 Basic annual expenses for dog and cat owners in USD (2021)
FIG. 22 Veterinary Oncology market restraint impact
FIG. 23 Market Participation Categorization
FIG. 24 Company market position analysis
FIG. 25 Market Leaders & Innovators
FIG. 26 Major deals & strategic alliances analysis
FIG. 27 Veterinary Oncology market: Therapy movement analysis
FIG. 28 Veterinary Oncology Market: Therapy Dashboard
FIG. 29 Surgery market, 2016 - 2030 (USD Million)
FIG. 30 Radiotherapy market, 2016 - 2030 (USD Million)
FIG. 31 Chemotherapy market, 2016 - 2030 (USD Million)
FIG. 32 Immunotherapy market, 2016 - 2030 (USD Million)
FIG. 33 Others market, 2016 - 2030 (USD Million)
FIG. 34 Veterinary Oncology market: Animal Type movement analysis
FIG. 35 Veterinary Oncology Market: Animal Type Dashboard
FIG. 36 Canine market, 2016 - 2030 (USD Million)
FIG. 37 Feline market, 2016 - 2030 (USD Million)
FIG. 38 Veterinary Oncology market: Cancer Type movement analysis
FIG. 39 Veterinary Oncology Market: Cancer Type Dashboard
FIG. 40 Lymphoma market, 2016 - 2030 (USD Million)
FIG. 41 Mast cell cancer market, 2016 - 2030 (USD Million)
FIG. 42 Mammary and squamous cell cancer market, 2016 - 2030 (USD Million)
FIG. 43 Others market, 2016 - 2030 (USD Million)
FIG. 44 Regional marketplace: Key takeaways
FIG. 45 Regional outlook, 2021 & 2030
FIG. 46 North America veterinary oncology market, 2016 - 2030 (USD million)
FIG. 47 U.S. Veterinary oncology market, 2016 - 2030 (USD million)
FIG. 48 Canada veterinary oncology market, 2016 - 2030 (USD million)
FIG. 49 Europe veterinary oncology market, 2016 - 2030 (USD million)
FIG. 50 Germany veterinary oncology market, 2016 - 2030 (USD million)
FIG. 51 U.K. veterinary oncology market, 2016 - 2030 (USD million)
FIG. 52 France veterinary oncology market, 2016 - 2030 (USD million)
FIG. 53 Italy veterinary oncology market, 2016 - 2030 (USD million)
FIG. 54 Spain veterinary oncology market, 2016 - 2030 (USD million)
FIG. 55 Asia Pacific veterinary oncology market, 2016 - 2030 (USD million)
FIG. 56 China veterinary oncology market, 2016 - 2030 (USD million)
FIG. 57 Japan veterinary oncology market, 2016 - 2030 (USD million)
FIG. 58 India veterinary oncology market, 2016 - 2030 (USD million)
FIG. 59 Latin America veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 60 Brazil veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 61 Mexico veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 62 MEA veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 63 South Africa veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 1 Market segmentation
FIG. 2 Market research process
FIG. 3 Data triangulation techniques
FIG. 4 Primary research pattern
FIG. 5 Market research approaches
FIG. 6 Value-chain-based sizing & forecasting
FIG. 7 QFD modeling for market share assessment
FIG. 8 Market formulation & validation
FIG. 9 Target population & treatment rate for the U.S.
FIG. 10 Treatment cost analysis
FIG. 11 Commodity flow analysis
FIG. 12 Veterinary oncology market snapshot 2021 (USD Million)
FIG. 13 Parent market outlook
FIG. 14 Ancillary market outlook
FIG. 15 Penetration &growth prospect mapping by Technology, 2021
FIG. 16 Consumer behavior analysis
FIG. 17 Market influencing analysis
FIG. 18 Technology timeline analysis
FIG. 19 Veterinary Oncology market dynamics
FIG. 20 Veterinary Oncology market driver impact
FIG. 21 Basic annual expenses for dog and cat owners in USD (2021)
FIG. 22 Veterinary Oncology market restraint impact
FIG. 23 Market Participation Categorization
FIG. 24 Company market position analysis
FIG. 25 Market Leaders & Innovators
FIG. 26 Major deals & strategic alliances analysis
FIG. 27 Veterinary Oncology market: Therapy movement analysis
FIG. 28 Veterinary Oncology Market: Therapy Dashboard
FIG. 29 Surgery market, 2016 - 2030 (USD Million)
FIG. 30 Radiotherapy market, 2016 - 2030 (USD Million)
FIG. 31 Chemotherapy market, 2016 - 2030 (USD Million)
FIG. 32 Immunotherapy market, 2016 - 2030 (USD Million)
FIG. 33 Others market, 2016 - 2030 (USD Million)
FIG. 34 Veterinary Oncology market: Animal Type movement analysis
FIG. 35 Veterinary Oncology Market: Animal Type Dashboard
FIG. 36 Canine market, 2016 - 2030 (USD Million)
FIG. 37 Feline market, 2016 - 2030 (USD Million)
FIG. 38 Veterinary Oncology market: Cancer Type movement analysis
FIG. 39 Veterinary Oncology Market: Cancer Type Dashboard
FIG. 40 Lymphoma market, 2016 - 2030 (USD Million)
FIG. 41 Mast cell cancer market, 2016 - 2030 (USD Million)
FIG. 42 Mammary and squamous cell cancer market, 2016 - 2030 (USD Million)
FIG. 43 Others market, 2016 - 2030 (USD Million)
FIG. 44 Regional marketplace: Key takeaways
FIG. 45 Regional outlook, 2021 & 2030
FIG. 46 North America veterinary oncology market, 2016 - 2030 (USD million)
FIG. 47 U.S. Veterinary oncology market, 2016 - 2030 (USD million)
FIG. 48 Canada veterinary oncology market, 2016 - 2030 (USD million)
FIG. 49 Europe veterinary oncology market, 2016 - 2030 (USD million)
FIG. 50 Germany veterinary oncology market, 2016 - 2030 (USD million)
FIG. 51 U.K. veterinary oncology market, 2016 - 2030 (USD million)
FIG. 52 France veterinary oncology market, 2016 - 2030 (USD million)
FIG. 53 Italy veterinary oncology market, 2016 - 2030 (USD million)
FIG. 54 Spain veterinary oncology market, 2016 - 2030 (USD million)
FIG. 55 Asia Pacific veterinary oncology market, 2016 - 2030 (USD million)
FIG. 56 China veterinary oncology market, 2016 - 2030 (USD million)
FIG. 57 Japan veterinary oncology market, 2016 - 2030 (USD million)
FIG. 58 India veterinary oncology market, 2016 - 2030 (USD million)
FIG. 59 Latin America veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 60 Brazil veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 61 Mexico veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 62 MEA veterinary oncology market, 2016 - 2030 (USD Million)
FIG. 63 South Africa veterinary oncology market, 2016 - 2030 (USD Million)
